Biocon Limited (BOM:532523)
366.00
+3.65 (1.01%)
At close: Nov 20, 2026
Biocon Employees
Biocon had 16,447 employees as of March 31, 2026. The number of employees increased by 132 or 0.81% since March 31, 2024.
Employees
16,447
Change
132
Growth
0.81%
Revenue / Employee
10.59M INR
Profits / Employee
274.88K INR
Market Cap
593.35B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16,447 | 132 | 0.81% |
| Mar 31, 2024 | 16,315 | -230 | -1.39% |
| Mar 31, 2023 | 16,545 | 1,545 | 10.30% |
| Mar 31, 2022 | 15,000 | 1,500 | 11.11% |
| Mar 31, 2021 | 13,500 | 891 | 7.07% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biocon | 16,447 |
| Anthem Biosciences | 2,282 |
| Panacea Biotec | 2,102 |
| OneSource Specialty Pharma | 1,674 |
| Concord Biotech | 1,624 |
| Dishman Carbogen Amcis | 934 |
| Lyka Labs | 648 |
| Zota Health Care | 635 |
Biocon News
- 9 days ago - Kiran Mazumdar-Shaw Praises Youngster For 'Jarvis' Inspired Smart Home Assistant That Works Offline - NDTV
- 18 days ago - Biocon Transcript: Q2 26/27 - Transcripts
- 18 days ago - Biocon Quarterly report: Q2 2027 - Filings
- 18 days ago - Biocon Slides: Q2 2027 - Filings
- 4 weeks ago - Biocon Annual report - Filings
- 5 weeks ago - Biocon settles Roche's US patent lawsuit over proposed breast-cancer drug copy - Reuters
- 2 months ago - Biocon's Pertuzumab Biosimilar Receives Positive EMA CHMP Recommendation - Nasdaq
- 2 months ago - Biocon Signs Brazil Pertuzumab Deal With Bahiafarma And Bionovis - Nasdaq